Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy - ScienceDirect
10-K/A 1 tv496133_10ka.htm 10-K/A UNITED
Exploring role of transglutaminase in patients with glioblas | OTT
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease | NEJM
ZED 1227 – Trusted Resource for Celiac Disease.
Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies | Semantic Scholar
Document
Celiac Disease: Genetics, Enzymes, Environment, Immunity, and Treatment | by Ahmed Mousa | Medium
Full article: Challenges to drug discovery for celiac disease and approaches to overcome them
Nutrients | Free Full-Text | New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options | HTML
Celiac Disease and Non-celiac Wheat Sensitivity: State of Art of Non-dietary Therapies | Semantic Scholar
ZED-1227
PLOS ONE: Double-Blind Randomized Clinical Trial: Gluten versus Placebo Rechallenge in Patients with Lymphocytic Enteritis and Suspected Celiac Disease
Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases - Gastroenterology
10-K/A 1 tv496133_10ka.htm 10-K/A UNITED
10-K/A 1 tv496133_10ka.htm 10-K/A UNITED
Potential celiac disease drug reduces intestinal damage, new study finds | BeyondCeliac.org
Study of a new treatment for celiac disease moves forward | BeyondCeliac.org
Drug Development Pipeline | BeyondCeliac.org
Novel therapies for celiac disease. (1) Endopeptidases: latiglutenase... | Download Scientific Diagram
Summary of Phase II Clinical Trials Treatment Class Agent Mechanism of... | Download Scientific Diagram
Nutrients | Free Full-Text | New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options | HTML
ZED1227 prevents increased mucosal injury in celiac disease
Nutrients | Free Full-Text | New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options | HTML
Signs of progress for celiac disease drugs | BeyondCeliac.org
Novel Nondietary Therapies for Celiac Disease - Cellular and Molecular Gastroenterology and Hepatology
Anokion Announces KAN-101 Phase 1 Success & Phase 2 Plans | Celiac Disease Foundation
